Mathew Moslow
NURS240: Mental Health Clinical Concept Project
It is fair to say that one of the biggest problems faced by psychiatric and mental health care patients and professionals alike is medication compliance, particularly among individuals diagnosed with schizophrenia. In patients with such delicate and sometimes taking medications that have a very narrow therapeutic index the medication regimen is key and any deviation could not only cost them temporary sanity or psychosis, it could mean the end of their lives.
Dilla and Ciudad (2013) approached the issue of nonadherence to antipsychotic medications in schizophrenia with a systematic framework, turning their attention to the often-overlooked economic fallout. Their findings illustrated a harsh reality: the cost of noncompliance extends far beyond clinical setbacks, accumulating into a substantial financial burden for both healthcare systems and society at large. In parallel, further research echoed this concern, pointing to the considerable monetary losses that accompany medication nonadherence—losses that quietly compound with each missed dose, each relapse, each preventable hospitalization.